Literature DB >> 33509957

Effectiveness of a specialised breathlessness service for patients with advanced disease in Germany: a pragmatic fast track randomised controlled trial (BreathEase).

Michaela Schunk1,2, Lien Le3, Zulfiya Syunyaeva4,5, Birgit Haberland6, Susanne Tänzler6, Ulrich Mansmann3,2, Larissa Schwarzkopf7,8,5, Hildegard Seidl7,2,9, Sabine Streitwieser6, Miriam Hofmann3, Thomas Müller3, Tobias Weiß10, Philipp Morawietz10, Eva Annette Rehfuess3,2, Rudolf Maria Huber4,5, Ursula Berger3,2, Claudia Bausewein6.   

Abstract

Entities:  

Year:  2021        PMID： 33509957     DOI： 10.1183/13993003.02139-2020

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  2 in total

1.  BreathEase: rationale, design and recruitment of a randomised trial and embedded mixed-methods study of a multiprofessional breathlessness service in early palliative care.

Authors:  Michaela Schunk; Ursula Berger; Lien Le; Eva Rehfuess; Larissa Schwarzkopf; Sabine Streitwieser; Thomas Müller; Miriam Hofmann; Rolf Holle; Rudolf Maria Huber; Ulrich Mansmann; Claudia Bausewein
Journal:  ERJ Open Res       Date:  2021-10-18

2.  Neurodoron® for Stress Impairments: A Prospective, Multicenter Non-Interventional Trial.

Authors:  Juliane Hellhammer; Katja Schmidt; Cristina Semaca; Rebecca Hufnagel
Journal:  Evid Based Complement Alternat Med       Date:  2022-02-25       Impact factor: 2.629
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.